Drugs / FDG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04275453 | Jan 2020 → Jan 2022 overdue | — | University of Pennsylvania | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FDG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04275453 ↗ |
| Modality | Diagnostic / imaging agent | “FDG is a FDA approved radiotracer” NCT04275453 ↗ |